Identification of a novel redox sensor that mediates delayed activation of stress-responsive MAPK pathways

1.

Kyriakis, J. M. & Avruch, J. Mammalian MAPK signal transduction pathways

activated by stress and inflammation: a 10-year update. Physiol. Rev. 92, 689-737 (2012).

2.

Takekawa, M., Posas, F. & Saito, H. A human homolog of the yeast Ssk2/Ssk22

MAP kinase kinases, MTK1, mediates stress-induced activation of the p38 and JNK

pathways. EMBO J. 16, 4973-4982 (1997).

3.

Chi, H., Sarkisian, M. R., Rakic, P. & Flavell, R. A. Loss of mitogen-activated

protein kinase kinase kinase 4 (MEKK4) results in enhanced apoptosis and defective

neural tube development. Proc. Natl. Acad. Sci. U. S. A. 102, 3846-3851 (2005).

4.

Chi, H., Lu, B., Takekawa, M., Davis, R. J. & Flavell, R. A.

GADD45beta/GADD45gamma and MEKK4 comprise a genetic pathway mediating

STAT4-independent IFNgamma production in T cells. EMBO J. 23, 1576-1586 (2004).

5.

Mita, H., Tsutsui, J., Takekawa, M., Witten, E. A. & Saito, H. Regulation of

MTK1/MEKK4 kinase activity by its N-terminal autoinhibitory domain and GADD45

binding. Mol. Cell. Biol. 22, 4544-4555 (2002).

6.

Takekawa, M. & Saito, H. A family of stress-inducible GADD45-like proteins

mediate activation of the stress-responsive MTK1/MEKK4 MAPKKK. Cell 95, 521530 (1998).

7.

Miyake, Z., Takekawa, M., Ge, Q. & Saito, H. Activation of MTK1/MEKK4 by

GADD45 through induced N-C dissociation and dimerization-mediated trans

autophosphorylation of the MTK1 kinase domain. Mol. Cell. Biol. 27, 2765-2776 (2007).

8.

Cross, C. E., Halliwell, B., Borish, E. T., Pryor, W. A., Ames, B. N., Saul, R. L.,

McCord, J. M. & Harman, D. Oxygen radicals and human disease. Ann. Intern. Med.

107, 526-545 (1987).

9.

Finkel, T. Signal transduction by reactive oxygen species. J. Cell Biol. 194, 7-15

(2011).

10.

Lambeth, J. D. NOX enzymes and the biology of reactive oxygen. Nat. Rev.

Immunol. 4, 181-189 (2004).

11.

Brand, M. D. The sites and topology of mitochondrial superoxide production.

Exp. Gerontol. 45, 466-472 (2010).

62

12.

Meyer, Y., Buchanan, B. B., Vignols, F. & Reichheld, J. P. Thioredoxins and

glutaredoxins: unifying elements in redox biology. Annu. Rev. Genet. 43, 335-367

(2009).

13.

Schieber, M. & Chandel, N. S. ROS function in redox signaling and oxidative

stress. Curr. Biol. 24, R453-62 (2014).

14.

Drummond, G. R., Selemidis, S., Griendling, K. K. & Sobey, C. G. Combating

oxidative stress in vascular disease: NADPH oxidases as therapeutic targets. Nat. Rev.

Drug Discov. 10, 453-471 (2011).

15.

Shukla, V., Mishra, S. K. & Pant, H. C. Oxidative stress in neurodegeneration.

Adv. Pharmacol. Sci. 2011, 572634 (2011).

16.

Kallis, G. B. & Holmgren, A. Differential reactivity of the functional sulfhydryl

groups of cysteine-32 and cysteine-35 present in the reduced form of thioredoxin from

Escherichia coli. J. Biol. Chem. 255, 10261-10265 (1980).

17.

Arner, E. S. & Holmgren, A. Physiological functions of thioredoxin and

thioredoxin reductase. Eur. J. Biochem. 267, 6102-6109 (2000).

18.

Nordberg, J. & Arner, E. S. Reactive oxygen species, antioxidants, and the

mammalian thioredoxin system. Free Radic. Biol. Med. 31, 1287-1312 (2001).

19.

Liu, Y. & Min, W. Thioredoxin promotes ASK1 ubiquitination and degradation

to inhibit ASK1-mediated apoptosis in a redox activity-independent manner. Circ. Res.

90, 1259-1266 (2002).

20.

Tobiume, K., Saitoh, M. & Ichijo, H. Activation of apoptosis signal-regulating

kinase 1 by the stress-induced activating phosphorylation of pre-formed oligomer. J.

Cell. Physiol. 191, 95-104 (2002).

21.

Saitoh, M., Nishitoh, H., Fujii, M., Takeda, K., Tobiume, K., Sawada, Y.,

Kawabata, M., Miyazono, K. & Ichijo, H. Mammalian thioredoxin is a direct inhibitor

of apoptosis signal-regulating kinase (ASK) 1. EMBO J. 17, 2596-2606 (1998).

22.

Fujino, G., Noguchi, T., Matsuzawa, A., Yamauchi, S., Saitoh, M., Takeda, K.

& Ichijo, H. Thioredoxin and TRAF family proteins regulate reactive oxygen speciesdependent activation of ASK1 through reciprocal modulation of the N-terminal

homophilic interaction of ASK1. Mol. Cell. Biol. 27, 8152-8163 (2007).

23.

Arango Duque, G. & Descoteaux, A. Macrophage cytokines: involvement in

immunity and infectious diseases. Front. Immunol. 5, 491 (2014).

63

24.

Takekawa, M., Tatebayashi, K., Itoh, F., Adachi, M., Imai, K. & Saito, H. Smad-

dependent GADD45beta expression mediates delayed activation of p38 MAP kinase by

TGF-beta. EMBO J. 21, 6473-6482 (2002).

25.

Kaneki, M., Kharbanda, S., Pandey, P., Yoshida, K., Takekawa, M., Liou, J. R.,

Stone, R. & Kufe, D. Functional role for protein kinase Cbeta as a regulator of stressactivated protein kinase activation and monocytic differentiation of myeloid leukemia

cells. Mol. Cell. Biol. 19, 461-470 (1999).

26.

Aragon, C. M., Rogan, F. & Amit, Z. Dose- and time-dependent effect of an acute

3-amino-1,2,4-triazole injection on rat brain catalase activity. Biochem. Pharmacol. 42,

699-702 (1991).

27.

Wynn, R., Cocco, M. J. & Richards, F. M. Mixed disulfide intermediates during

the reduction of disulfides by Escherichia coli thioredoxin. Biochemistry 34, 1180711813 (1995).

28.

Ichijo, H., Nishida, E., Irie, K., ten Dijke, P., Saitoh, M., Moriguchi, T., Takagi,

M., Matsumoto, K., Miyazono, K. & Gotoh, Y. Induction of apoptosis by ASK1, a

mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science

275, 90-94 (1997).

29.

Forman, H. J. & Torres, M. Redox signaling in macrophages. Mol. Aspects Med.

22, 189-216 (2001).

30.

Noguchi, T., Takeda, K., Matsuzawa, A., Saegusa, K., Nakano, H., Gohda, J.,

Inoue, J. & Ichijo, H. Recruitment of tumor necrosis factor receptor-associated factor

family proteins to apoptosis signal-regulating kinase 1 signalosome is essential for

oxidative stress-induced cell death. J. Biol. Chem. 280, 37033-37040 (2005).

31.

Kamata, H., Honda, S., Maeda, S., Chang, L., Hirata, H. & Karin, M. Reactive

oxygen species promote TNFalpha-induced death and sustained JNK activation by

inhibiting MAP kinase phosphatases. Cell 120, 649-661 (2005).

32.

Lee, S. R., Kwon, K. S., Kim, S. R. & Rhee, S. G. Reversible inactivation of

protein-tyrosine phosphatase 1B in A431 cells stimulated with epidermal growth factor.

J. Biol. Chem. 273, 15366-15372 (1998).

33.

Lee, S. R., Kwon, K. S., Kim, S. R. & Rhee, S. G. Reversible inactivation of the

tumor suppressor PTEN by H2O2. J. Biol. Chem. 277, 20336-20342 (2002).

64

34.

Hurst, S. M., Wilkinson, T. S., McLoughlin, R. M., Jones, S., Horiuchi, S.,

Yamamoto, N., Rose-John, S., Fuller, G. M., Topley, N. & Jones, S. A. Il-6 and its

soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment

seen during acute inflammation. Immunity 14, 705-714 (2001).

35.

Matsuzawa, A., Saegusa, K., Noguchi, T., Sadamitsu, C., Nishitoh, H., Nagai,

S., Koyasu, S., Matsumoto, K., Takeda, K. & Ichijo, H. ROS-dependent activation of

the TRAF6-ASK1-p38 pathway is selectively required for TLR4-mediated innate

immunity. Nat. Immunol. 6, 587-592 (2005).

36.

Nishimoto, N. & Kishimoto, T. Inhibition of IL-6 for the treatment of

inflammatory diseases. Curr. Opin. Pharmacol. 4, 386-391 (2004).

37.

Moore, K. J., Sheedy, F. J. & Fisher, E. A. Macrophages in atherosclerosis: a

dynamic balance. Nat. Rev. Immunol. 13, 709-721 (2013).

65

...